Signal active
Bio
Dr. Conley leads new investments for the firm while serving as an active Director on many of Paladin’s portfolio company Boards. Paul joined the Paladin team after more than 15 years of previous R&D and entrepreneurial experience. As founding CEO of BrightScale, he led the commercialization of a patented multi-core microprocessor technology in the HDTV market. As founding CEO of Appfluent Technology, he led the commercialization of patented in-memory distributed database technologies in the enterprise IT market.
Prior to taking the entrepreneurial route, he spent nearly a decade in multidisciplinary R&D roles in the areas of high-performance computing, applied physics and biomedical engineering, including postdoctoral positions at the Los Alamos National Laboratory.
Location
Palo Alto, California, United States, North America
Social
Primary Organization
2001
171
68
50
11-50
Financial Services, Venture Capital, Finance
Jobs history
4
General Inception
Founder & CEO
Invalid date - Current
Paladin Capital Group
Managing Director
Invalid date - Current
Menlo Micro
Director
Invalid date - Current
Managing Director
2015 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Paul Conley is the Managing Director at Paladin Capital Group, based in United States, North America. With a background in Financial Services, Paul Conley has a rich history of leadership and innovation. Paul Conley studied MS Mechanical & Aerospace Engineering @ University of Virginia. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
Jacob Becraft
CEO, co-founder
Benjamin Kim
No designation
Joshua Meier
Founder
Ron Alfa
No designation
Investment portfolio
1
0
Personal investment
1
Annouced Date | Organization Name | Funding Round | Money Raised |
---|---|---|---|
Dec 06, 2022 | Infinimmune | Seed Round - Infinimmune | 12.0M |
Partner investment
15
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Feb 01, 2021 | NanoCellect Biomedical | Series C - NanoCellect Biomedical | - | 15.0M |
Aug 13, 2021 | NanoCellect Biomedical | Series D - NanoCellect Biomedical | - | 20.0M |
Dec 24, 2021 | - | Series B - ONI | - | 75.0M |
Mar 09, 2022 | Menlo Micro | Series C - Menlo Micro | Paladin Capital Group | 150.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.